# Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

> **NCT01523132** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 545 (actual)

## Conditions studied

- Breast Cancer
- Persistent Pain
- Lymphedema
- Neuropathic Pain
- Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01523132
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 545 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523132, "Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01523132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*